Marianne Uteng
InvestorManaging Director at Novartis Venture Fund
Basel, Switzerland
Writes $5M – $10M checks · typically $7.5M
Find your path to Marianne
Sign up to see every warm intro you have to Marianne
- Paths you didn't know you had: your email and LinkedIn already hold routes to Marianne. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Marianne Uteng, PhD, is a Managing Director at Novartis Venture Fund in Basel. She previously worked in Novartis Global Drug Development and its Pre-Clinical Safety Department, leading teams on safety assessments for early and late-stage programs, and supported Novartis BD&L Search & Evaluation while building collaborations with biotech companies and academia. She holds an MSc in Biochemistry from the University of Oslo and a PhD in Molecular Biology, Cell Biology & Biophysics from a joint EMBL–University of Oslo program.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Per curated public sources.
Colleagues at Novartis Venture Fund
Frequently asked questions
- Who is Marianne Uteng?
- Marianne Uteng, PhD, is a Managing Director at Novartis Venture Fund in Basel. She previously worked in Novartis Global Drug Development and its Pre-Clinical Safety Department, leading teams on safety assessments for early and late-stage programs, and supported Novartis BD&L Search & Evaluation while building collaborations with biotech companies and academia. She holds an MSc in Biochemistry from the University of Oslo and a PhD in Molecular Biology, Cell Biology & Biophysics from a joint EMBL–University of Oslo program.
- Where does Marianne Uteng work?
- Marianne Uteng is Managing Director at Novartis Venture Fund.
- What does Marianne Uteng invest in?
- Marianne Uteng invests in Biotech.
- What check size does Marianne Uteng write?
- Marianne Uteng typically writes checks of $5M – $10M.
- What companies has Marianne Uteng invested in?
- Investments tracked here include AstronauTX Ltd, CatalYm, Epsilogen, Tagworks Pharmaceuticals.
About this profile. Compiled from public sources — Novartis Venture Fund's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights








